Clinical Study

Movement Velocity and Fluidity Improve after Armeo®Spring Rehabilitation in Children Affected by Acquired and Congenital Brain Diseases: An Observational Study

Table 3

Results of instrumental measures on the entire study group.(CP+ABI, N=43).

T0 
Median (IQR)
Tm 
Median (IQR)
T1 
Median (IQR)
p Friedmanp Wilcoxon 
Bonf-corrected
T0 vs TmT0 vs T1Tm vs T1

ABI+CP (N=43)HPR ()166.0 (52.9)148.3 (30.0)144.8 (47.3)0.0020.0280.0131.000
horOS [cm]1.8 (1.0)1.3 (0.8)1.1 (1.0)0.0110.0340.0101.000
verOS [cm]1.0 (0.3)1.0 (0.5)0.3 (0.8)0.471
Mean vel [cm/s]2.8 (1.5)3.5 (1.3)4.0 (1.0)<0.001<0.001<0.0010.005
Max vel [cm/s]6.8 (3.6)9.8 (3.5)10.5 (3.4)<0.001<0.001<0.0010.073
NvelPeaks2.0 (0.8)1.8 (0.5)1.5 (1.0)<0.001<0.001<0.0010.048
Norm jerk787 (1352)298 (1019)304 (394)0.0020.0070.0060.545

Parameters were extracted using the Matlab-based tool realized by Merlo and collaborators [23], before (T0), during (Tm) and after (T1) intervention. P values refer to the nonparametric paired Wilcoxon test. HPR: Hand Path Ratio; horOS: horizontal overshooting; verOS: vertical overshooting; Mean/Max vel: mean/maximum velocity; NvelPeak: number of velocity peaks; Norm jerk: normalized jerk.